| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | AZD6244 | CCLE | pan-cancer | AAC | -0.27 | 4e-08 |
| mRNA | PD-0325901 | CCLE | pan-cancer | AAC | -0.26 | 5e-08 |
| mRNA | TAE684 | CCLE | pan-cancer | AAC | -0.25 | 8e-07 |
| mRNA | AEW541 | CCLE | pan-cancer | AAC | -0.26 | 8e-07 |
| mRNA | Nilotinib | CCLE | pan-cancer | AAC | -0.26 | 5e-06 |
| mRNA | Crizotinib | CCLE | pan-cancer | AAC | -0.16 | 0.002 |
| mRNA | Sorafenib | CCLE | pan-cancer | AAC | -0.15 | 0.005 |
| mRNA | Irinotecan | CCLE | pan-cancer | AAC | 0.16 | 0.008 |
| mRNA | 17-AAG | CCLE | pan-cancer | AAC | -0.13 | 0.02 |
| mRNA | RAF265 | CCLE | pan-cancer | AAC | -0.13 | 0.02 |